Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $779.9100 (0.29%) ($779.9100 - $779.9100) on Tue. Oct. 31, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.23% (three month average) | RSI | 23 | Latest Price | $779.9100(0.29%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.6% a day on average for past five trading days. | Weekly Trend | REGN declines -3.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XLV(66%) IBB(57%) DIA(54%) SDY(53%) SPLV(53%) | Factors Impacting REGN price | REGN will decline at least -0.615% in a week (0% probabilities). VXX(-46%) VIXM(-32%) EDOC(-27%) TBT(-22%) UNG(-16%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.615% (StdDev 1.23%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $814.06 | 5 Day Moving Average | $784.06(-0.53%) | 10 Day Moving Average | $795.42(-1.95%) | 20 Day Moving Average | $814.06(-4.2%) | To recent high | -7.8% | To recent low | 6.5% | Market Cap | $82.693b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |